Genmab — Januar 2020
-
Case 2: Overcoming High Risk in Myeloma https://www.youtube.com/watch?v=nCWXvR7kOz8
-
-
Thx E L. In this one she says that Isa doesn't need as much pre-medication as dara. https://www.targetedonc.com/investigator-perspectives/target-cd38-rr-mm/icaria-mm-phase-iii-trial-overview
-
-
Det trog jeg ikke du kan konkludere
-
Jeg Thor mere på at JNJ endnu ikke har givet Genmab besked
-
tror
-
Jim Omel på Twitter: "I’ve yet to see a negative report on Dara. If it were oral (which it’s not), it should be in the drinking water of myeloma pts! Oh my"!https://conquer-magazine.com/ash-2019-mm-wrap-up?view=article&artid=1128:daratumumab-added-to-standard-therapy-longer-survival-in-newly-diagnosed-multiple-myeloma&utm_source=bronto&utm_medium=email&utm_term=Daratumumab+Added+to+Standard+Therapy+%3D+Longer+Survival+in+Newly+Diagnosed+Multiple+Myeloma&utm_content=The+Latest+in+Multiple+Myeloma
I og med der IKKE er kommet profit warning fra Genmab kan vi vel nu konkludere de 3 mia er hjemme. Da der allerede er guided med de 3 mia kommer der vel ikke nødvendigvis en pressemeddelelse så mon ikke vi skal afvente JNJ årsregnskab 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind